China NT Pharma Group Company Limited provided consolidated earnings guidance for the year ended December 31, 2015. The group expects to record a substantial increase in net profit by more than 40 times for the year ended December 31, 2015 as compared to the year ended December 31, 2014. Such increase is primarily attributable to the significant improvement of gross profit margin of its proprietary products and decrease of finance cost.